NCT03366597 is a NA clinical trial of Sevoflurane in Congenital Heart Disease, sponsored by Jun Ma.

Who is sponsoring NCT03366597?

NCT03366597 is sponsored by Jun Ma.

What drugs are being tested in NCT03366597?

Interventions in NCT03366597: Sevoflurane.

What condition does NCT03366597 study?

NCT03366597 studies Congenital Heart Disease, Infant, Premature, Diseases.

Is NCT03366597 still recruiting?

NCT03366597 is currently status unknown. Last updated 11 February 2021.

Last reviewed 2021-02-11 · How we verify

NCT03366597

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Research of the Effect of Sevoflurane on Brain-protection of Cardiac Surgery in Infants.

Status unknown NA Last updated 11 February 2021

What this trial tests

NA trial testing Sevoflurane in Congenital Heart Disease in 100 participants. Status unknown.

Timeline

20 January 2018

Primary endpoint
28 December 2021

28 December 2022

Quick facts

Lead sponsor	Jun Ma
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	20 January 2018
Primary completion	28 December 2021
Estimated completion	28 December 2022
Sites	1 location across China

Drugs / interventions tested

Sevoflurane — full drug profile →

Conditions studied

Congenital Heart Disease — all drugs for Congenital Heart Disease →
Infant, Premature, Diseases — all drugs for Infant, Premature, Diseases →

Sponsor

Jun Ma

Who can join

Under 3, any sex, with Congenital Heart Disease or Infant, Premature, Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To observe the effect of sevoflurane on the concentration of S100β and regional cerebral oxygen saturation in infants with congenital heart disease undergoing cardiac surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Current Status of Neuroprotection in Congenital Heart Disease.
Kobayashi K, Liu C, Jonas RA, Ishibashi N. · · 2021 · cited 7× · PMID 34943311 · DOI 10.3390/children8121116

Verify or expand the search:

Other trials of Sevoflurane

Trials testing the same drug.

NCT07525648 — Comparison of the Effects of Sevoflurane and Desflurane on Optic Nerve Sheath Diameter During Laparoscopic Surgery · NA · recruiting
NCT07511634 — Comparison of Sevoflurane and Desflurane on ANI in Patients Undergoing General Anesthesia: a Prospective Randomized Cont · NA · not yet recruiting
NCT07440758 — Low-Flow Sevoflurane and Desflurane Anesthesia in Laparoscopic Cholecystectomy · NA · not yet recruiting
NCT07295158 — Effect of Sevoflurane vs Desflurane on Mechanical Power in Laparoscopic Cholecystectomy · NA · recruiting
NCT07152912 — Impact of Isoflurane and Sevoflurane on Oxidative Stress in Patients Undergoing Laparoscopic Cholecystectomy · NA · recruiting

Other recruiting trials for Congenital Heart Disease

Currently open trials in the same condition.

NCT07193719 — Influence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children · Phase 1, PHASE2 · recruiting
NCT07023367 — Parent Navigator Program (PNP) to Improve Outcomes in Latino/x Children and Parents · NA · recruiting
NCT06833320 — Propranolol Treatment for Postoperative Chylothorax · Phase 1, PHASE2 · recruiting
NCT06668389 — Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary · Phase 4 · recruiting
NCT06872320 — The Influence of Probiotics on Metabolome and Heart Rate Variability in Heart Failure of Structure Heart Disease · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03366597 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jun Ma
Last refreshed: 11 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03366597.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing